1. Home
  2. Food & Beverages
  3. Global Bioactive Protein and Peptides Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Bioactive Protein and Peptides Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Publication Month: Feb 2023 | No. of Pages: 111 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.
According to our (Global Info Research) latest study, the global Bioactive Protein and Peptides market size was valued at USD 1744.9 million in 2022 and is forecast to a readjusted size of USD 2733.5 million by 2029 with a CAGR of 6.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.
This report is a detailed and comprehensive analysis for global Bioactive Protein and Peptides market. Both quantitative and qualitative analyses are presented by company, by region & country, by Source and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bioactive Protein and Peptides market size and forecasts, in consumption value ($ Million), 2018-2029
Global Bioactive Protein and Peptides market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Bioactive Protein and Peptides market size and forecasts, by Source and by Application, in consumption value ($ Million), 2018-2029
Global Bioactive Protein and Peptides market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bioactive Protein and Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bioactive Protein and Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gelita, Kerry Group, Vital Proteins, Rousselot and BRF Ingredients, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Bioactive Protein and Peptides market is split by Source and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Source and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Source
Plant Source
Animal Source
Market segment by Application
Functional Food
Dietary Supplements
Personal Care
Animal Nutrition
Other
Market segment by players, this report covers
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Reborn Biotech
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bioactive Protein and Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bioactive Protein and Peptides, with revenue, gross margin and global market share of Bioactive Protein and Peptides from 2018 to 2023.
Chapter 3, the Bioactive Protein and Peptides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Source and application, with consumption value and growth rate by Source, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Bioactive Protein and Peptides market forecast, by regions, source and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Bioactive Protein and Peptides.
Chapter 13, to describe Bioactive Protein and Peptides research findings and conclusion.

1 Market Overview
1.1 Product Overview and Scope of Bioactive Protein and Peptides
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Bioactive Protein and Peptides by Source
1.3.1 Overview: Global Bioactive Protein and Peptides Market Size by Source: 2018 Versus 2022 Versus 2029
1.3.2 Global Bioactive Protein and Peptides Consumption Value Market Share by Source in 2022
1.3.3 Plant Source
1.3.4 Animal Source
1.4 Global Bioactive Protein and Peptides Market by Application
1.4.1 Overview: Global Bioactive Protein and Peptides Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Functional Food
1.4.3 Dietary Supplements
1.4.4 Personal Care
1.4.5 Animal Nutrition
1.4.6 Other
1.5 Global Bioactive Protein and Peptides Market Size & Forecast
1.6 Global Bioactive Protein and Peptides Market Size and Forecast by Region
1.6.1 Global Bioactive Protein and Peptides Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Bioactive Protein and Peptides Market Size by Region, (2018-2029)
1.6.3 North America Bioactive Protein and Peptides Market Size and Prospect (2018-2029)
1.6.4 Europe Bioactive Protein and Peptides Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Bioactive Protein and Peptides Market Size and Prospect (2018-2029)
1.6.6 South America Bioactive Protein and Peptides Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Bioactive Protein and Peptides Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Gelita
2.1.1 Gelita Details
2.1.2 Gelita Major Business
2.1.3 Gelita Bioactive Protein and Peptides Product and Solutions
2.1.4 Gelita Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Gelita Recent Developments and Future Plans
2.2 Kerry Group
2.2.1 Kerry Group Details
2.2.2 Kerry Group Major Business
2.2.3 Kerry Group Bioactive Protein and Peptides Product and Solutions
2.2.4 Kerry Group Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Kerry Group Recent Developments and Future Plans
2.3 Vital Proteins
2.3.1 Vital Proteins Details
2.3.2 Vital Proteins Major Business
2.3.3 Vital Proteins Bioactive Protein and Peptides Product and Solutions
2.3.4 Vital Proteins Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Vital Proteins Recent Developments and Future Plans
2.4 Rousselot
2.4.1 Rousselot Details
2.4.2 Rousselot Major Business
2.4.3 Rousselot Bioactive Protein and Peptides Product and Solutions
2.4.4 Rousselot Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rousselot Recent Developments and Future Plans
2.5 BRF Ingredients
2.5.1 BRF Ingredients Details
2.5.2 BRF Ingredients Major Business
2.5.3 BRF Ingredients Bioactive Protein and Peptides Product and Solutions
2.5.4 BRF Ingredients Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BRF Ingredients Recent Developments and Future Plans
2.6 Bunge Ltd
2.6.1 Bunge Ltd Details
2.6.2 Bunge Ltd Major Business
2.6.3 Bunge Ltd Bioactive Protein and Peptides Product and Solutions
2.6.4 Bunge Ltd Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bunge Ltd Recent Developments and Future Plans
2.7 Ingredia Nutritional
2.7.1 Ingredia Nutritional Details
2.7.2 Ingredia Nutritional Major Business
2.7.3 Ingredia Nutritional Bioactive Protein and Peptides Product and Solutions
2.7.4 Ingredia Nutritional Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ingredia Nutritional Recent Developments and Future Plans
2.8 Gelatines Weishardt
2.8.1 Gelatines Weishardt Details
2.8.2 Gelatines Weishardt Major Business
2.8.3 Gelatines Weishardt Bioactive Protein and Peptides Product and Solutions
2.8.4 Gelatines Weishardt Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Gelatines Weishardt Recent Developments and Future Plans
2.9 PanTheryx
2.9.1 PanTheryx Details
2.9.2 PanTheryx Major Business
2.9.3 PanTheryx Bioactive Protein and Peptides Product and Solutions
2.9.4 PanTheryx Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 PanTheryx Recent Developments and Future Plans
2.10 Hubei Reborn Biotech
2.10.1 Hubei Reborn Biotech Details
2.10.2 Hubei Reborn Biotech Major Business
2.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Product and Solutions
2.10.4 Hubei Reborn Biotech Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hubei Reborn Biotech Recent Developments and Future Plans
2.11 Seagarden
2.11.1 Seagarden Details
2.11.2 Seagarden Major Business
2.11.3 Seagarden Bioactive Protein and Peptides Product and Solutions
2.11.4 Seagarden Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Seagarden Recent Developments and Future Plans
2.12 Shandong Hengxin Biotech
2.12.1 Shandong Hengxin Biotech Details
2.12.2 Shandong Hengxin Biotech Major Business
2.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Product and Solutions
2.12.4 Shandong Hengxin Biotech Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shandong Hengxin Biotech Recent Developments and Future Plans
2.13 Baotou Dongbao Bio-Tech
2.13.1 Baotou Dongbao Bio-Tech Details
2.13.2 Baotou Dongbao Bio-Tech Major Business
2.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product and Solutions
2.13.4 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Baotou Dongbao Bio-Tech Recent Developments and Future Plans
2.14 Wuhan Jiushengtang Biotech
2.14.1 Wuhan Jiushengtang Biotech Details
2.14.2 Wuhan Jiushengtang Biotech Major Business
2.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product and Solutions
2.14.4 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wuhan Jiushengtang Biotech Recent Developments and Future Plans
2.15 Morinaga Milk
2.15.1 Morinaga Milk Details
2.15.2 Morinaga Milk Major Business
2.15.3 Morinaga Milk Bioactive Protein and Peptides Product and Solutions
2.15.4 Morinaga Milk Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Morinaga Milk Recent Developments and Future Plans
2.16 Collagile
2.16.1 Collagile Details
2.16.2 Collagile Major Business
2.16.3 Collagile Bioactive Protein and Peptides Product and Solutions
2.16.4 Collagile Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Collagile Recent Developments and Future Plans
2.17 Nuritas
2.17.1 Nuritas Details
2.17.2 Nuritas Major Business
2.17.3 Nuritas Bioactive Protein and Peptides Product and Solutions
2.17.4 Nuritas Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Nuritas Recent Developments and Future Plans
2.18 SmartPEP
2.18.1 SmartPEP Details
2.18.2 SmartPEP Major Business
2.18.3 SmartPEP Bioactive Protein and Peptides Product and Solutions
2.18.4 SmartPEP Bioactive Protein and Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 SmartPEP Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Bioactive Protein and Peptides Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Bioactive Protein and Peptides by Company Revenue
3.2.2 Top 3 Bioactive Protein and Peptides Players Market Share in 2022
3.2.3 Top 6 Bioactive Protein and Peptides Players Market Share in 2022
3.3 Bioactive Protein and Peptides Market: Overall Company Footprint Analysis
3.3.1 Bioactive Protein and Peptides Market: Region Footprint
3.3.2 Bioactive Protein and Peptides Market: Company Product Type Footprint
3.3.3 Bioactive Protein and Peptides Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Source
4.1 Global Bioactive Protein and Peptides Consumption Value and Market Share by Source (2018-2023)
4.2 Global Bioactive Protein and Peptides Market Forecast by Source (2024-2029)
5 Market Size Segment by Application
5.1 Global Bioactive Protein and Peptides Consumption Value Market Share by Application (2018-2023)
5.2 Global Bioactive Protein and Peptides Market Forecast by Application (2024-2029)
6 North America
6.1 North America Bioactive Protein and Peptides Consumption Value by Source (2018-2029)
6.2 North America Bioactive Protein and Peptides Consumption Value by Application (2018-2029)
6.3 North America Bioactive Protein and Peptides Market Size by Country
6.3.1 North America Bioactive Protein and Peptides Consumption Value by Country (2018-2029)
6.3.2 United States Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
6.3.3 Canada Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
6.3.4 Mexico Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Bioactive Protein and Peptides Consumption Value by Source (2018-2029)
7.2 Europe Bioactive Protein and Peptides Consumption Value by Application (2018-2029)
7.3 Europe Bioactive Protein and Peptides Market Size by Country
7.3.1 Europe Bioactive Protein and Peptides Consumption Value by Country (2018-2029)
7.3.2 Germany Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
7.3.3 France Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
7.3.5 Russia Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
7.3.6 Italy Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Bioactive Protein and Peptides Consumption Value by Source (2018-2029)
8.2 Asia-Pacific Bioactive Protein and Peptides Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Bioactive Protein and Peptides Market Size by Region
8.3.1 Asia-Pacific Bioactive Protein and Peptides Consumption Value by Region (2018-2029)
8.3.2 China Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
8.3.3 Japan Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
8.3.4 South Korea Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
8.3.5 India Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
8.3.7 Australia Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
9 South America
9.1 South America Bioactive Protein and Peptides Consumption Value by Source (2018-2029)
9.2 South America Bioactive Protein and Peptides Consumption Value by Application (2018-2029)
9.3 South America Bioactive Protein and Peptides Market Size by Country
9.3.1 South America Bioactive Protein and Peptides Consumption Value by Country (2018-2029)
9.3.2 Brazil Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
9.3.3 Argentina Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Bioactive Protein and Peptides Consumption Value by Source (2018-2029)
10.2 Middle East & Africa Bioactive Protein and Peptides Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Bioactive Protein and Peptides Market Size by Country
10.3.1 Middle East & Africa Bioactive Protein and Peptides Consumption Value by Country (2018-2029)
10.3.2 Turkey Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
10.3.4 UAE Bioactive Protein and Peptides Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Bioactive Protein and Peptides Market Drivers
11.2 Bioactive Protein and Peptides Market Restraints
11.3 Bioactive Protein and Peptides Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Bioactive Protein and Peptides Industry Chain
12.2 Bioactive Protein and Peptides Upstream Analysis
12.3 Bioactive Protein and Peptides Midstream Analysis
12.4 Bioactive Protein and Peptides Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Tables and Figures

List of Tables
Table 1. Global Bioactive Protein and Peptides Consumption Value by Source, (USD Million), 2018 & 2022 & 2029
Table 2. Global Bioactive Protein and Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Bioactive Protein and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Bioactive Protein and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Gelita Company Information, Head Office, and Major Competitors
Table 6. Gelita Major Business
Table 7. Gelita Bioactive Protein and Peptides Product and Solutions
Table 8. Gelita Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Gelita Recent Developments and Future Plans
Table 10. Kerry Group Company Information, Head Office, and Major Competitors
Table 11. Kerry Group Major Business
Table 12. Kerry Group Bioactive Protein and Peptides Product and Solutions
Table 13. Kerry Group Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Kerry Group Recent Developments and Future Plans
Table 15. Vital Proteins Company Information, Head Office, and Major Competitors
Table 16. Vital Proteins Major Business
Table 17. Vital Proteins Bioactive Protein and Peptides Product and Solutions
Table 18. Vital Proteins Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Vital Proteins Recent Developments and Future Plans
Table 20. Rousselot Company Information, Head Office, and Major Competitors
Table 21. Rousselot Major Business
Table 22. Rousselot Bioactive Protein and Peptides Product and Solutions
Table 23. Rousselot Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Rousselot Recent Developments and Future Plans
Table 25. BRF Ingredients Company Information, Head Office, and Major Competitors
Table 26. BRF Ingredients Major Business
Table 27. BRF Ingredients Bioactive Protein and Peptides Product and Solutions
Table 28. BRF Ingredients Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. BRF Ingredients Recent Developments and Future Plans
Table 30. Bunge Ltd Company Information, Head Office, and Major Competitors
Table 31. Bunge Ltd Major Business
Table 32. Bunge Ltd Bioactive Protein and Peptides Product and Solutions
Table 33. Bunge Ltd Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bunge Ltd Recent Developments and Future Plans
Table 35. Ingredia Nutritional Company Information, Head Office, and Major Competitors
Table 36. Ingredia Nutritional Major Business
Table 37. Ingredia Nutritional Bioactive Protein and Peptides Product and Solutions
Table 38. Ingredia Nutritional Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Ingredia Nutritional Recent Developments and Future Plans
Table 40. Gelatines Weishardt Company Information, Head Office, and Major Competitors
Table 41. Gelatines Weishardt Major Business
Table 42. Gelatines Weishardt Bioactive Protein and Peptides Product and Solutions
Table 43. Gelatines Weishardt Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Gelatines Weishardt Recent Developments and Future Plans
Table 45. PanTheryx Company Information, Head Office, and Major Competitors
Table 46. PanTheryx Major Business
Table 47. PanTheryx Bioactive Protein and Peptides Product and Solutions
Table 48. PanTheryx Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. PanTheryx Recent Developments and Future Plans
Table 50. Hubei Reborn Biotech Company Information, Head Office, and Major Competitors
Table 51. Hubei Reborn Biotech Major Business
Table 52. Hubei Reborn Biotech Bioactive Protein and Peptides Product and Solutions
Table 53. Hubei Reborn Biotech Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Hubei Reborn Biotech Recent Developments and Future Plans
Table 55. Seagarden Company Information, Head Office, and Major Competitors
Table 56. Seagarden Major Business
Table 57. Seagarden Bioactive Protein and Peptides Product and Solutions
Table 58. Seagarden Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Seagarden Recent Developments and Future Plans
Table 60. Shandong Hengxin Biotech Company Information, Head Office, and Major Competitors
Table 61. Shandong Hengxin Biotech Major Business
Table 62. Shandong Hengxin Biotech Bioactive Protein and Peptides Product and Solutions
Table 63. Shandong Hengxin Biotech Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Shandong Hengxin Biotech Recent Developments and Future Plans
Table 65. Baotou Dongbao Bio-Tech Company Information, Head Office, and Major Competitors
Table 66. Baotou Dongbao Bio-Tech Major Business
Table 67. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product and Solutions
Table 68. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Baotou Dongbao Bio-Tech Recent Developments and Future Plans
Table 70. Wuhan Jiushengtang Biotech Company Information, Head Office, and Major Competitors
Table 71. Wuhan Jiushengtang Biotech Major Business
Table 72. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product and Solutions
Table 73. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Wuhan Jiushengtang Biotech Recent Developments and Future Plans
Table 75. Morinaga Milk Company Information, Head Office, and Major Competitors
Table 76. Morinaga Milk Major Business
Table 77. Morinaga Milk Bioactive Protein and Peptides Product and Solutions
Table 78. Morinaga Milk Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Morinaga Milk Recent Developments and Future Plans
Table 80. Collagile Company Information, Head Office, and Major Competitors
Table 81. Collagile Major Business
Table 82. Collagile Bioactive Protein and Peptides Product and Solutions
Table 83. Collagile Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Collagile Recent Developments and Future Plans
Table 85. Nuritas Company Information, Head Office, and Major Competitors
Table 86. Nuritas Major Business
Table 87. Nuritas Bioactive Protein and Peptides Product and Solutions
Table 88. Nuritas Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nuritas Recent Developments and Future Plans
Table 90. SmartPEP Company Information, Head Office, and Major Competitors
Table 91. SmartPEP Major Business
Table 92. SmartPEP Bioactive Protein and Peptides Product and Solutions
Table 93. SmartPEP Bioactive Protein and Peptides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. SmartPEP Recent Developments and Future Plans
Table 95. Global Bioactive Protein and Peptides Revenue (USD Million) by Players (2018-2023)
Table 96. Global Bioactive Protein and Peptides Revenue Share by Players (2018-2023)
Table 97. Breakdown of Bioactive Protein and Peptides by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Bioactive Protein and Peptides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Bioactive Protein and Peptides Players
Table 100. Bioactive Protein and Peptides Market: Company Product Type Footprint
Table 101. Bioactive Protein and Peptides Market: Company Product Application Footprint
Table 102. Bioactive Protein and Peptides New Market Entrants and Barriers to Market Entry
Table 103. Bioactive Protein and Peptides Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Bioactive Protein and Peptides Consumption Value (USD Million) by Source (2018-2023)
Table 105. Global Bioactive Protein and Peptides Consumption Value Share by Source (2018-2023)
Table 106. Global Bioactive Protein and Peptides Consumption Value Forecast by Source (2024-2029)
Table 107. Global Bioactive Protein and Peptides Consumption Value by Application (2018-2023)
Table 108. Global Bioactive Protein and Peptides Consumption Value Forecast by Application (2024-2029)
Table 109. North America Bioactive Protein and Peptides Consumption Value by Source (2018-2023) & (USD Million)
Table 110. North America Bioactive Protein and Peptides Consumption Value by Source (2024-2029) & (USD Million)
Table 111. North America Bioactive Protein and Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Bioactive Protein and Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Bioactive Protein and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Bioactive Protein and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Bioactive Protein and Peptides Consumption Value by Source (2018-2023) & (USD Million)
Table 116. Europe Bioactive Protein and Peptides Consumption Value by Source (2024-2029) & (USD Million)
Table 117. Europe Bioactive Protein and Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Bioactive Protein and Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Bioactive Protein and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Bioactive Protein and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Bioactive Protein and Peptides Consumption Value by Source (2018-2023) & (USD Million)
Table 122. Asia-Pacific Bioactive Protein and Peptides Consumption Value by Source (2024-2029) & (USD Million)
Table 123. Asia-Pacific Bioactive Protein and Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Bioactive Protein and Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Bioactive Protein and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Bioactive Protein and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Bioactive Protein and Peptides Consumption Value by Source (2018-2023) & (USD Million)
Table 128. South America Bioactive Protein and Peptides Consumption Value by Source (2024-2029) & (USD Million)
Table 129. South America Bioactive Protein and Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Bioactive Protein and Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Bioactive Protein and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Bioactive Protein and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Bioactive Protein and Peptides Consumption Value by Source (2018-2023) & (USD Million)
Table 134. Middle East & Africa Bioactive Protein and Peptides Consumption Value by Source (2024-2029) & (USD Million)
Table 135. Middle East & Africa Bioactive Protein and Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Bioactive Protein and Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Bioactive Protein and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Bioactive Protein and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Bioactive Protein and Peptides Raw Material
Table 140. Key Suppliers of Bioactive Protein and Peptides Raw Materials
List of Figures
Figure 1. Bioactive Protein and Peptides Picture
Figure 2. Global Bioactive Protein and Peptides Consumption Value by Source, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Bioactive Protein and Peptides Consumption Value Market Share by Source in 2022
Figure 4. Plant Source
Figure 5. Animal Source
Figure 6. Global Bioactive Protein and Peptides Consumption Value by Source, (USD Million), 2018 & 2022 & 2029
Figure 7. Bioactive Protein and Peptides Consumption Value Market Share by Application in 2022
Figure 8. Functional Food Picture
Figure 9. Dietary Supplements Picture
Figure 10. Personal Care Picture
Figure 11. Animal Nutrition Picture
Figure 12. Other Picture
Figure 13. Global Bioactive Protein and Peptides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Bioactive Protein and Peptides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Bioactive Protein and Peptides Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Bioactive Protein and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Bioactive Protein and Peptides Consumption Value Market Share by Region in 2022
Figure 18. North America Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Bioactive Protein and Peptides Revenue Share by Players in 2022
Figure 24. Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Bioactive Protein and Peptides Market Share in 2022
Figure 26. Global Top 6 Players Bioactive Protein and Peptides Market Share in 2022
Figure 27. Global Bioactive Protein and Peptides Consumption Value Share by Source (2018-2023)
Figure 28. Global Bioactive Protein and Peptides Market Share Forecast by Source (2024-2029)
Figure 29. Global Bioactive Protein and Peptides Consumption Value Share by Application (2018-2023)
Figure 30. Global Bioactive Protein and Peptides Market Share Forecast by Application (2024-2029)
Figure 31. North America Bioactive Protein and Peptides Consumption Value Market Share by Source (2018-2029)
Figure 32. North America Bioactive Protein and Peptides Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Bioactive Protein and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Bioactive Protein and Peptides Consumption Value Market Share by Source (2018-2029)
Figure 38. Europe Bioactive Protein and Peptides Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Bioactive Protein and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 41. France Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Bioactive Protein and Peptides Consumption Value Market Share by Source (2018-2029)
Figure 46. Asia-Pacific Bioactive Protein and Peptides Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Bioactive Protein and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 48. China Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 51. India Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Bioactive Protein and Peptides Consumption Value Market Share by Source (2018-2029)
Figure 55. South America Bioactive Protein and Peptides Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Bioactive Protein and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Bioactive Protein and Peptides Consumption Value Market Share by Source (2018-2029)
Figure 60. Middle East and Africa Bioactive Protein and Peptides Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Bioactive Protein and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Bioactive Protein and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 65. Bioactive Protein and Peptides Market Drivers
Figure 66. Bioactive Protein and Peptides Market Restraints
Figure 67. Bioactive Protein and Peptides Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Bioactive Protein and Peptides in 2022
Figure 70. Manufacturing Process Analysis of Bioactive Protein and Peptides
Figure 71. Bioactive Protein and Peptides Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source




Companies Mentioned
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Reborn Biotech
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP

Reason to Buy

  • Current and future of Food & Beverages Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Food & Beverages Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Food & Beverages Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Food & Beverages Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets